PRESENTATION
FY2020 — Results presentation
FY2020PDF · 84 pages12.2 MB
1 1 for the year ended 30 June 2020 -- 1 of 84 -- 2 Core new business to R19 173m Normalised operating profit to R6 069m Headline earnings to R296m to R8 409m Normalised operating profit before reserving for future COVID-19 impacts Normalised headline earnings to R3 747m -- 2 of 84 -- 3 The Group focused on capital strength and liquidity Operating performance was resilient with operating profit up 9%, new business up 5% and actuarial dynamics in line with expectation Interest rate movements had a R4.8bn pre-tax effect on headline earnings, but minimal impact on cashflows, solvency or liquidity and excluded from normalised earnings A COVID-19 reserve of R3.4bn was created to cater for all future COVID-19 impacts. 13% of the life claims provision has been used with the balance of the provision sufficient for a potential second wave Growth engine remains robust with pleasing results from Established, remarkable profit growth from Emerging and an investment of R2.2bn into New businesses, which are seeing considerable traction Core new business to R19 173m Normalised operating profit to R6 069m Headline earnings to R296m to R8 409m Normalised operating profit before reserving for future COVID-19 impacts Normalised headline earnings to R3 747m -- 3 of 84 -- 4 Our strategic response to the pandemic Keep every staff member safe Maintain connectivity Live out our values Ensure business continuity Ensure products are fit-for-purpose Keep people healthy and active Ensure operating profit strong with appropriate and conservative reserve for COVID-19 Minimise the impact on liquidity and solvency Protect the capital plan Maintain financial strength and resilience Support the healthcare system Strengthen the healthcare system Play an outsized role COVID Alert SA app DISCOVERY talks COVID-19 information hub Support our country Protect our people Protect and support our clients “My pick so far is Discovery, it had an American astronaut talk about isolation, al-Qaeda hostage on resilience, Jessica Ennis-Hill gave a live aerobics class” Vitality at Home COVID-19 concessions Behavioural shared value -- 4 of 84 -- 5 Globally two waves are emerging but SA has passed the peak SA’s stringent lockdown was successful in flattening and delaying the peak • Early lockdown reduced infection rate • Allowing more time for development of treatment insights • Resulting in greater capacity in healthcare system South Africa -- 5 of 84 -- 6 28% 20% 19% 15% 15% 8% 8% 6% 5% 4% 7% 4% 5% 3% 2% High care ward ICU ward Ventilation SA is benefiting from advancements in treatment - 5 10 15 20 25 30 35 40 45 50 Rest of SA KZN Gauteng EC WC New York health system overwhelmed at 50 new daily infections per 100 000 lives -60% reduction in average length of stay of COVID-19 admissions SA has passed the peak, decreasing daily new infections Advancements in treatment insights improved efficiency and reduced severity Average LOS 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 11-May 11-Jun 11-Jul 11-Aug -25% reduction in ICU deaths -51% reduction in cases requiring high acuity intervention Proportion of recovered cases SA Total Expected mortality in early stages was 0.38%, now reduced to 0.28%-0.32% -- 6 of 84 -- 7 The impact of lockdown on behaviour is evident 0% 20% 40% 60% 80% 100% 120% 140% 160% 180% 07-Jan 14-Jan 21-Jan 28-Jan 04-Feb 11-Feb 18-Feb 25-Feb 04-Mar 11-Mar 18-Mar 25-Mar 01-Apr 08-Apr 15-Apr 22-Apr 29-Apr 06-May 13-May 20-May 27-May 03-Jun 10-Jun 17-Jun 24-Jun 01-Jul 08-Jul 15-Jul 22-Jul 29-Jul 05-Aug 12-Aug 19-Aug 26-Aug Lockdown level 5 Lockdown level 3 Lockdown level 4 Lockdown level 2 Bank spend* *Indexed to average January 2020 Healthy Food Physical activity 12% reduction in level 5, now 11% above prior levels 43% reduction in level 5, now 11% below prior levels 16% reduction in level 5, now 7% below prior levels 83% reduction in level 5, now 30% below prior levels Driving 2019 -- 7 of 84 -- 8 Our strategic focus areas Financial and social impact Foundation Businesses -- 8 of 84 -- 9 3 190 +5% 3 190 +5% 4 029 +25% -1 979 2 971 -8% -3 634 830 -14% -181 830 -14% 246 +59% 246 +59% SA Composite1 8 302 +11% 7 244 -3% 1 543 +104% -713 830 +9% 297 -49% -569 -272 -147% -1 193 UK Composite1 1 840 +38% 558 -58% 308 +91% 308 +91% 182 +72% 182 +72% New businesses -2 223 +70% -2 223 +70% Total 8 409 +9% -3 442 6 069 -22% -4 827 Rm SA Composite UK Composite Partner Composite 1 Excluding New initiatives 2 Net of discretionary margins (-2 3402) (-1 0582) (02) Operating profit before reserving for future COVID-19 impacts Reserve for future COVID-19 Interest rate effect Operating profit -- 9 of 84 -- 10 Operating performance was resilient with operating profit up 9%, new business up 5% and actuarial dynamics in line with expectation -- 10 of 84 -- 11 3 190 +5% 4 029 +25% 830 -14% 246 +59% SA Composite1 8 302 +11% 1 543 +104% 297 -49% UK Composite1 1 840 +38% 308 +91% 182 +72% New businesses -2 223 +70% Total 8 409 +9% Rm SA Composite UK Composite Partner Composite 1 Excluding New initiatives Operating profit before reserving for future COVID-19 impacts Resilient operating variances and cash generation. Robust capital and liquidity Strong asset gatherer. Earnings curtailed by once-off factors Operational excellence and strong retention. Earnings inflated by delayed claims due to the NHS co-opting private hospitals Executed on its turnaround plan. Set up for future recovery Strong quality of business. Scaling the Shared-Value Model Resilient revenue with operating leverage. Capitalise on enhanced relevance and leading global position Remarkable growth. Continued investment for long-term opportunities Bank migrations complete, fully deposit-funded. Rapid learnings to improve user experiences and value proposition Strong performance and supporting society. Driving efficiencies -- 11 of 84 -- 12 New business Rm 12 months to 30 Jun 2020 12 months to 30 Jun 2019 % change 6 101 6 695 -9% 2 286 2 312 -1% 2 667 2 604 +2% 1 238 1 346 -8% 1 257 1 291 -3% 1 089 1 041 +5% 1 134 922 +23% 3 575 2 518 +42% New businesses 825 386 +114% -5% +29% ESTABLISHED BUSINESSES EMERGING BUSINESS NEW 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug 0% 50% 100% 150% Jan Feb Mar Apr May Jun Jul Aug – vs 2019 level -- 12 of 84 -- 13 Resilient operating performance, actuarial dynamics within expectation Lapses – vs expected Claims – vs expected Life claims for Life Cover, Capital Disability and Severe Illness only VitalityLife lapse experience excludes once off process change in June Paid up 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June Withdrawals 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June 0% 50% 100% 150% Jan Feb Mar Apr May June -- 13 of 84 -- 14 A COVID-19 reserve of R3.4bn was created: 13% of the life claims provision has been used with the balance of the provision sufficient for a potential second wave -- 14 of 84 -- 15 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Cumulative actual Cumulative provision The COVID-19 claims reserve is appropriate and sufficient for a potential second wave Modelled 3 scenarios R-factors Actual deaths vs projected Actual progression - 20,000 40,000 60,000 80,000 100,000 120,000 Feb-20 Mar-20 Apr-20 May-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Low Medium High 46% population infected H2 20 23% population infected H2 20 6% population infected H2 20 - 10,000 20,000 30,000 40,000 50,000 60,000 70,000 Feb-20 Mar-20 Apr-20 May-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Low Medium High 8.7% population infected 20 6.6% population infected 20 6.1% population infected 20 of total life claims provision used Illustrative if second wave Sufficient if second wave Cumulative deaths Cumulative deaths South Africa Discovery March June May August 1 2 3 March June May August 1 2 3 - 20 40 60 80 100 120 140 160 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Low Medium High Actual - 100 200 300 400 500 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Low Medium High Actual Indicative Cumulative Discovery Life deaths Cumulative Vitality Life deaths of expected to date -- 15 of 84 -- 16 Authorisations in VH are starting to rebound, delays in seeking treatment could increase costs 0% 20% 40% 60% 80% 100% 120% Monthly authorisations per 1 000 lives CARDIAC ONCOLOGY PSYCHIATRY OVERALL Overall authorisations are still below pre-COVID-19 levels, August 82% of normal Delays in seeking oncology treatment could prove costly as cancers are likely to be more advanced Delays in treatment could manifest in increased severity costs and result in increased uncertainty in the reserving process 0% 20% 40% 60% 80% 100% 120% 140% Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Jul-21 Aug-21 Claims spend expected compared to authorisations received Claims shaping within the business plan Overall auths witnessed Expect above normal utilisation of services until policyholders and hospitals catch-up on treatments which have been delayed Assume: • 90% non-elective missed claims recur • 20% elective procedures missed will not come back • Cases delayed suffer additional costs due to COVID testing, additional overnight stays, or increased severity MUSCULOSKELETAL -- 16 of 84 -- 17 Interest rate movements had a R4.8bn pre-tax effect on headline earnings, but minimal impact on cashflows, solvency or liquidity and excluded from normalised earnings 0% 5% 10% 15% Jun-06 Jul-07 Aug-08 Sep-09 Oct-10 Nov-11 Dec-12 Jan-14 Feb-15 Mar-16 Apr-17 May-18 Jun-19 Real Nominal -4% -2% 0% 2% 4% 6% Jan-06 Jan-08 Jan-10 Jan-12 Jan-14 Jan-16 Jan-18 Jan-20 Real Nominal -- 17 of 84 -- 18 - 50 100 150 -200bps -150bps -50bps Base +50bps +180bps +250bps 10 year available cashflow 5 year available cashflow NRR SCR Cover - 50 100 150 Base -20bps -40bps -60bps -80bps -100bps SCR Cover NRR NRR & Hedge Return 110 90 Continued volatility in interest rates negatively affected headline earnings Record levels of interest rates Impact on Discovery Life and VitalityLife IFRS impact Lowest levels of real and nominal rates in history 25-year UK Real and Nominal Gilt Yields Highest levels of nominal rates in recent history Hedge protected against further decreases -80 -60 -40 -20 - 20 40 60 2019/10/12 2019/12/01 2020/01/20 2020/03/10 2020/04/29 2020/06/18 2020/08/07 Millions Liability Change Hedge TotalInclForwardRate Total impact Total impact 25-year Real and Nominal Yields Reinvestment risk Valuation risk SCR and cashflow stress to nominal interest rates, indexed to Base 0% 5% 10% 15% Jun-06 Jun-07 Jun-08 Jun-09 Jun-10 Jun-11 Jun-12 Jun-13 Jun-14 Jun-15 Jun-16 Jun-17 Jun-18 Jun-19 Jun-20 Real Nominal -4% -2% 0% 2% 4% 6% Jan-06 Jan-07 Jan-08 Jan-09 Jan-10 Jan-11 Jan-12 Jan-13 Jan-14 Jan-15 Jan-16 Jan-17 Jan-18 Jan-19 Jan-20 Real Nominal SCR and cashflow stress to nominal interest rates, indexed to Base 110 90 -- 18 of 84 -- 19 Growth engine remains robust with pleasing results from Established, remarkable profit growth from Emerging and an investment of R2.2bn into New businesses, which are seeing considerable traction -- 19 of 84 -- 20 The organic growth methodology -13% Invested in New 26% 14% FY18 – FY23 3% FY21 – FY25 R7.6bn -R2.2bn 3 190 4 029 830 1 543 297 246 308 182 VitalityInvest Discovery Business Insurance Umbrella Funds Vitality1 Rm * *Ignoring investment in future New initiatives ~5 years ~5 years ESTABLISHED EMERGING NEW Investment of 10% of profit * Normalised operating profit before reserving for future COVID-19 impacts Normalised operating profit 3 190 2 971 830 830 -272 +15% +74% R9.9bn R736m -- 20 of 84 -- 21 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Substantial and planned spend on New businesses; seeing considerable traction Majority on Bank 53% 11% Other Breakdown of FY20 operating loss Monthly new business run rate VitalityInvest DBI Umbrella Funds Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Monthly new business run rate Committed assets Vitality1 New over next 21 months July 2020 March 2022 BRAZIL SPAIN ITALY SAUDI ARABIA 21 months pipeline 3X POWERED BY POLAND CZECH REPUBLIC PORTUGAL MEXICO INDIA Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun -- 21 of 84 -- 22 The Group focused on capital strength and liquidity -- 22 of 84 -- 23 Cash management supports the growth methodology Cash generated from in-force 1 Movement in shareholder free cash Cash generated Cash used Funding Reinsurers Cash generated from in-force business R15.4bn Cash used net of funding Net cash flow Debt Tax, dividends and finance costs New business R3.9bn R8.0bn Net cash flow1 R3.8bn New businesses R2.6bn -- 23 of 84 -- 24 Debt is reducing Group is well capitalised and highly liquid Strongly capitalised Rm June 19 Cover June 20 Cover 1.6x 1.8x 1.7x 1.8x 1.4x 1.7x 1.5x 2.0x 1.6x Sufficient liquidity at the centre Highly liquid across the Group2 28% DHMS solvency 32.7% 1 Capital Adequacy Ratio 2 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 3 SA cash + undrawn committed facilities 1 SA Liquidity3 , R millions FLR - 2,000 4,000 6,000 8,000 10,000 FY18 FY19 FY20 R millions Jun-17 Dec-17 Jun-18 Dec-18 Jun-19 Dec-19 Jun-20 Jun-21 - 500 1,000 1,500 2,000 FY18 FY19 FY20 FY21 Liquid excess assets above regulatory capital requirements -- 24 of 84 -- 25 Opening EV VNB Unwind RDR Non-economic experience variances Non-economic methodology and assumption changes Operational EV Economic* Forex Other - finance costs and Group initiatives Change in capital and dividends Closing EV Return on Embedded Value 5% excluding forex and economic changes Operational EV Economic and other 76 398 71 217 70 834 *Economic experience variances and methodology & assumption changes -- 25 of 84 -- 26 Reconciliation to normalised headline earnings Rm 12 months ended Jun 2020 12 months ended Jun 2019 % change Profit from operations before reserving for future COVID impacts 8 409 7 747 +9% Reserve for future COVID-19 impacts, net of discretionary margins (2 340) Profit from operations 6 069 7 747 -22% Economic assumptions adjustments (4 830) Dilution gains from equity accounted investments 3 808 Gain on previously held interest in Discovery Card business 0 761 Finance charges excl. 1DP finance lease (1 218) (1 036) Foreign exchange gains 578 Other (79) (148) Profit before tax 523 8 132 -94% Tax (347) (1 518) Profit attributable to preference shareholders (81) (81) Loss attributable to non-controlling interest 2 Profit attributable to ordinary shareholders 97 6 533 -99% Dilution gains from equity-accounted investments, net of tax (3) (666) Gain on previously held interests in Discovery Card business - (761) Loss on de-recognition of assets net of tax 149 - Other 53 41 Headline earnings 296 5 147 -94% Economic assumption adjustments net of interest rate derivative and net of tax 3 584 – Other (133) (112) Normalised headline earnings 3 747 5 035 -26% -- 26 of 84 -- 27 The strategic foundation PURPOSE VALUES PEOPLE BRAND MODEL CAPABILITIES Make people healthier and enhance and protect their lives Great people Liberating the best in people Intellectual leadership Drive, tenacity and urgency Innovation and optimism Business astuteness and prudence Dazzle clients Integrity, honesty and fairness Best person for every role -- 27 of 84 -- 28 NATURE OF RISK TECHNOLOGY SOCIAL RESPONSIBILITY “We want revolutionary actuaries” Tesla launching insurance company - premiums based on data collected by cars’ internal sensors Global trends have the power to transform insurance markets and have been accelerated by COVID-19 The nature of risk is behavioural The nature of COVID-19 risk is behaviourial Accelerated rush online Social and environmental movements amplifying corporate responsibility • The rise of digital • Ways of work • Ecommerce • Telemedicine • Contactless The nature of behaviour on mortality Banking Motor Life Health “Digitally enabled, customer centric and drive engagement” “Deep understanding of risk and how to manage it” “Producing profitable solutions to the problems of people and planet, not profiting from producing problems for people or planet” Colin Mayer “It’s time to tie bank profits to customers financial health” -- 28 of 84 -- 29 Impact of risk factors on COVID-19 mortality COVID-19 risk is also behavioural Exercise No exercise 1.0 1.6 2.0 2.5 0.9 1.0 1.2 45 year old unengaged male 65 year old male No chronic conditions Hypertension Hypertension and diabetes No chronic conditions Hypertension Hypertension and diabetes -- 29 of 84 -- 30 Make people healthier and enhance and protect their lives Life insurance Health insurance Short-term insurance Long-term savings Banking -- 30 of 84 -- 31 Vitality platform underpinning all initiatives INCENTIVE LAYER TECHNOLOGY AND ANALYTICS LAYER INCENTIVE MEMBER BEHAVIORAL LAYER △ BEHAVIOR INCENTIVE DATA LAYER △ RISK △ BEHAVIOR PRICING LAYER VALUE △ RISK TECHNOLOGY AND ANALYTICS LAYER DATA LAYER BEHAVIORAL LAYER INCENTIVE LAYER PRICING LAYER INCENTIVE MEMBER △ BEHAVIOR INCENTIVE △ RISK △ BEHAVIOR VALUE △ RISK = x x x VALUE MEMBER SERVICE PRODUCT ACTIVE REWARDS 2020 for Seniors HEALTH BEHAVIORS CONTENT DEVELOPMENT Pre- commitment Nudge theory Loss Aversion BEHAVIORAL DESIGN GLOBAL INTEGRATED PARTNERS BEHAVIORS -> RISK FACTORS -> CHRONIC CONDITIONS -> MORTALITY RESEARCH COLLABORATIONS FRAMEWORK AND CO-DEVELOPERS CLIENTS 1 KOREA GERMANY FRANCE AUSTRIA ARGENTINA GROUP BENEFITS None Blue Bronze Silver Gold DYNAMIC PRICING WEDGE FUNDING -- 31 of 84 -- 32 Shared-Value dynamics manifest across all industries LIFE HEALTH MOTOR LONG-TERM SAVINGS Claims Lapses No VD Blue Bronze Silver Gold Diamond No VD Blue Bronze Silver Gold Diamond SA UK Market A Blue Bronze Silver Gold SA UK Blue Bronze Silver Gold SA UK Blue Bronze Silver Gold SA UK Market A Market B Market C Market D Blue Bronze Silver Gold None Blue Bronze Silver Gold Diamond None Blue Bronze Silver Gold Diamond -- 32 of 84 -- 33 Perfect composite model, #1 in every industry, and laboratory for shared value in financial services. A successful entry into banking The best insurer in the UK, making use of a composite Shared-Value Model Vitality is the world’s largest and most sophisticated behavioural platform linked to financial services, with disciplined execution Ping An Health delivers on its plan to become the leading health insurer in China with over 50m clients The four strategic strands -- 33 of 84 -- 34 UK COMPOSITE MODEL PARTNER COMPOSITE MODEL SA COMPOSITE MODEL -- 34 of 84 -- 35 1 2 3 4 5 6 The composite delivers superior outcomes and there is still a significant integration opportunity Composite delivers lower lapses and greater up-selling 1 2 3 4 Lapse rate by # of policies Premium size by # of policies 54 17 13 7 6 81 68 38 20 19 59 57 55 29 19 60 55 25 22 15 40% of Life clients have < 2 products Average product take- up <1.6 Common behaviour architecture with stacked incentives Still a significant composite opportunity -88% 1.5x Correlations between risk behaviours Holistic client view Efficient distribution 80% of retail clients only have 1 product 80% of employer groups only have 1 product Small (10-100) Medium (100-400) Large (400+) 6,200 corporates 1,200 corporates 500 corporates Group Risk Retirement Funds Healthy Company 90 20 2 -- 35 of 84 -- 36 J A S O N D J F M A M J J A S Accounts Retail deposits Credit facilities Clients J A S O N D J F M A M J J A S J A S O N D J F M A M J J A S J A S O N D J F M A M J J A S 2019 2020 2019 2020 2019 2020 2019 2020 Utilised R3.7bn As at 14 September -- 36 of 84 -- 37 Costs continue to be tightly managed in the Bank’s first year of operation R4 535m Actual R4 552m Expected Total spend since inception to date FY20 IFRS Result R1 171m Actual R1 179m Expected 43 348 1,179 29 353 1,171 Infrastructure Build Run Expected Actual FY20 spend (Rm) -- 37 of 84 -- 38 Strategic focus areas Prudent, deposit-led growth strategy, while ensuring the quality of the loan book Seamless migration of >223 000 clients Rapid learning and continuous improvement -- 38 of 84 -- 39 Successful and seamless completion of migration of FNB JV loan Book 0 100 200 300 400 500 600 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Thousands Discovery Bank account growth Card-by-card New-to-Bank Upgrade from Bin Still in Bin Apr-20 May-20 Jun-20 Jul-20 Bulk BIN Migrations Accounts migrated over from FNB to Discovery Bank 18k 61k 27k 63k -- 39 of 84 -- 40 Deposit growth Funding Capital resilience Deposit distribution Deposits exceeded the loan book, resulting in significant liquidity 0 1 2 3 4 J A S O N D J F M A M J J A S Retail Deposits Advances Funding surplus/ (shortfall) Rbn Current +20pp1 -30% 0% Percentage change in retail deposits Credit limit utilisation Current R3.5bn 1:percentage points 55% 14% 11% 5%3% 2%1% 1% 1% 1% 1% 7% R’000 3% 6% 12% 3% 64% 13% Blue Bronze Silver Gold Diamond VM not setup Vitality Money status Amount Wholesale and retail deposits Credit utilisation Surplus Rbn, as at 7 September (Excluding capital) 6.25 (3.56) 2.69 -- 40 of 84 -- 41 Credit quality Credit distribution Arrears Financial affluence The quality of the loan book is excellent and the Bank is maintaining a prudent credit growth strategy 0% 25% 50% 75% 100% Discovery Bank Market Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 0 100 200 300 400 500 600 700 800 Client Credit Score Exceptionally Low Risk Low Risk Medium Risk High Risk Very High Risk 35% 15% 19% 11% 6% 4% 3% 2% 1% 1% 1% 3% R’000 Group 1 = Most affluent (2019) Average credit score (2016 – 2019) lower than market 0% 2% 4% 6% 8% 10% 12% 14% 16% J F M A M J J Discovery Bank Market -- 41 of 84 -- 42 Learnings from Vitality Money Shared-Value fundamentals Value received by clients Blue Bronze Silver Gold Diamond Blue Bronze Silver Gold Diamond Blue Bronze Silver Gold Diamond Arrears rate Deposit levels Spend HealthyFood miles rewarded Active Rewards rings closed airtime and electricity transactions discounted -- 42 of 84 -- 43 New design of Vitality Money Retirement Debt Management Property Insurance Savings Determine Status and interest rates Engage and earn Discovery Miles Use your Discovery Miles Points to Miles Healthy Living Spend anywhere Exercise Drive Blue Bronze Silver Gold Diamond Spend Monetize Convert Donate Up to 75% Up to R15 per Refined proposition 1 2 3 A new face of Shared-Value Banking Bank accounts and balances The “armadillo” -- 43 of 84 -- 44 Refined user experience with behavioural nudges Accounts, Behaviours, Status and Interest rates Immediately understand your status and your financial behaviours and scores and the impact on your interest rates Landing page Status and where to improve Nudges and their impact Earning Discovery Miles Three simple ways: Points to Miles, Spend at partners; Spend anywhere Exercise Points to Miles Partner Spend to Miles -- 44 of 84 -- 45 New business Rm Lapses Membership Normalised operating profit Rm to R3 190m 2016 2017 2018 2019 2020 lives under administration 5.0% 4.5% YTD Jun-19 YTD Jun-20 to R6 101m 2016 2017 2018 2019 2020 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 DHMS Restricted Schemes -- 45 of 84 -- 46 DHMS growth Rm Closed scheme growth Retail product growth Growth impacted by the contraction in employment - 500 1,000 1,500 2,000 2,500 3,000 3,500 2016 2017 2018 2019 2020 Type I Type II 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 lives closed schemes lives Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 Apr-19 Jul-19 Oct-19 Jan-20 Apr-20 Healthy Company Gap cover Primary Care of DH revenue year-on-year growth Type I: new employer groups Type II: new employees on existing groups -- 46 of 84 -- 47 Membership and growth Lapses and stability Security and surplus 1 Council of Medical Schemes Reductions in elective hospital admissions and general healthcare utilisation emerging from COVID-19 unaudited solvency credit rating annualised lapse rate Plan movements stability Downgrade No movement Upgrade lives market share1 as at Sep 2019 Growing market share in a contracting open medical scheme environment 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 year-on-year change 2.8% 2.9% 94.3% 2002 2005 2008 2011 2014 2017 Aug-20 Year end reserve position 2020 surplus build-up emerging from COVID-19 Jan-20 Mar-20 May-20 Jul-20 R26.6bn R19.2bn -- 47 of 84 -- 48 - 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2-Mar 9-Mar 16-Mar 23-Mar 30-Mar 6-Apr 13-Apr 20-Apr 27-Apr 4-May 11-May 18-May 25-May 1-Jun 8-Jun 15-Jun 22-Jun 29-Jun 6-Jul 13-Jul 20-Jul 27-Jul 3-Aug 10-Aug 17-Aug 24-Aug 31-Aug Solvency build-up driven by the decline in non-COVID-19 healthcare utilisation Weekday hospital admissions index Weekday OH claims index Total admissions Medical admissions Surgical admissions LOCKDOWN LEVEL 5 LOCKDOWN LEVEL 4 LOCKDOWN LEVEL 3 Rolling 3 day average OTC scripts issued Physical GP consultations Baseline Rolling 3 day average - 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2-Mar 9-Mar 16-Mar 23-Mar 30-Mar 6-Apr 13-Apr 20-Apr 27-Apr 4-May 11-May 18-May 25-May 1-Jun 8-Jun 15-Jun 22-Jun 29-Jun 6-Jul 13-Jul 20-Jul 27-Jul 3-Aug 10-Aug 17-Aug 24-Aug 31-Aug LOCKDOWN LEVEL 5 LOCKDOWN LEVEL 4 LOCKDOWN LEVEL 3 Baseline LOCKDOWN LEVEL 2 LOCKDOWN LEVEL 2 -- 48 of 84 -- 49 COVID-related admissions Hospital utilisation Hospital occupancy Significant reduction in hospital utilisation with excess capacity even at COVID-19 peak COVID admissions peaked in July 2020 Overall hospital utilisation has reduced by 27% YTD Even at peak cases in July, hospital occupancy levels were below 2019 0.6% 1.4% 6.3% 15.7% 8.5% 4.0% Apr May Jun Jul Aug Sep COVID as proportion of total admissions Single hospital - 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 100,000 Jan Feb Mar Apr May Jun Jul Aug Total DH member hospital admissions 2020 COVID Admissions 2020 Non COVID admissions 2019 Admissions 0 200 400 600 800 1000 1200 0 200 400 600 800 1000 1200 2020 July volumes 2019 July volumes Hospital occupancy levels (2019 vs. 2020) -- 49 of 84 -- 50 Convergence of data-driven insights to identify high-risk members and care at home with remote monitoring has saved lives Significant improvement in health outcomes Significant reduction in mortality Statistically proven to reduce admissions, lower case severity and improve mortality outcomes through early detection of deterioration and proactive care 100% 73% Baseline risk Pulse oximeter impact Pulse oximeter impact on hospitalisation -27% 100% 62% Baseline risk Pulse oximeter impact Pulse oximeter impact on mortality -38% at-risk clients identified DH members received support at home and remote monitoring -- 50 of 84 -- 51 Managing healthcare costs in 2021 and beyond Principles informing future management of contribution rates: Affordable increases for 2021 and equilibrium in 2022 Max (pre-2021) CPI + 0% CPI + 2% CPI + 4% CPI + 6% CPI + 8% CPI + 10% 2016 2017 2018 2019 2020 DHMS Top 6 open schemes Difference in contribution Increases: DHMS vs Top 6 (2016-2020) DHMS contribution increases are consistently below industry levels based on favourable tariff and utilisation experience Min (pre-2021) 2015 2016 2017 2018 2019 Discovery Health average inflation rates Pricing for 2020 should reflect anticipated experience post-COVID-19 Correction of latent Non-COVID demand projected for Q3 2021 -- 51 of 84 -- 52 Strong cashflow, capital and liquidity position New business Normalised operating profit to R2 286m 2016 2017 2018 2019 2020 to R2 971m Solvency coverage Cashflow generated of liquidity Operating Profit pre-COVID-19 +25% Net economic impact Normalised operating profit Operating profit before reserving for future COVID-19 impact 2016 2017 2018 2019 2020 Resilient operating variances 260 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Non-economic experience variances (Rm) Positive non-economic variances Includes Discovery Invest -- 52 of 84 -- 53 146% 80% >R10m 2019 2020 Positive operational experience variances; policy alterations impacted by COVID-19 2020 operational experience variances Improved mortality experience Policy alterations impacted by COVID-19 relief -241 -74 -82 16 -342 Jun 2017 Jun 2018 Jun 2019 Dec 2019 Jun 2020 Historic policy alterations variances (Rm) Claims experience AvE Rm 115% 104% 93% 98% 2019 H1 H2 2020 Significant decrease in large life claims 0.7% of gross FY20 claims Life claims by cause of death (Rm) Includes Discovery Invest Lapses and surrenders Mortality and morbidity Premium and fee income Policy alterations Other Total Lapses and surrenders Mortality and morbidity Premium and fee income Policy alterations Other Total 2019 2020 -- 53 of 84 -- 54 Sufficient coverage for a second wave Cumulative Actual Cumulative Provision Actual progression of Discovery Life claims provision used Sufficient if second wave COVID-19 provision for excess claims and lapses Actual COVID-19 claims experience COVID-19 provision is appropriate and sufficient for a potential second wave Discovery Life COVID-19 Provision split (Rm) Claims: 957m Lapses: 1 022m Total COVID-19 Provisions raised (Rm) 1 979 Release of Margin (Rm) (921) Net COVID-19 Provision impact (Rm) 1 058 - 20 40 60 80 100 120 140 Apr-20 May-20 Jun-20 Jul-20 Aug-20 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 79 80+ Vitality status, age-group claims shown as count per 1 000 lives Gross monthly claims (Rm) Claims by Vitality status (count) Claims by age- group (count) None Blue Bronze Silver Gold/Diamond -- 54 of 84 -- 55 Premiums and Fees Claims and PH reserves Operational Costs Cashflows from existing NB Strain Cashflow before FinRe Net FinRe Life and Invest Net cashflow Jun-20 Strong cash emergence R millions Significantly improved capital position High levels of liquidity coverage R millions Includes once-off R1.8bn gain from Asset- Liability optimisation 182% 172% 159% Jun20 Dec19 Jun19 125% SCR target Driven by: • Mass lapse RI treaty (Dec19) • Higher interest rates at Jun20 • COVID provisions • Balance sheet optimisation R4.1bn Assets available to meet liquidity needs c.R500m FinRe available from July 2020 Additional Robust position evident in strong cashflow, capital coverage and liquidity 14 775 6 006 3 247 2 543 -- 55 of 84 -- 56 2019 2020 Value of new business and embedded value impacted by COVID-19 and economic assumption changes Reduced value of new business and margin Analysis of embedded value: Life & Invest to R31.8bn 421 923 2020 2019 Impacted by: • Lower sales due to lockdown/restricted underwriting • Economic assumption changes • COVID-19 stress assumptions Jun-19 New Business Expected unwind incl New Business Experience Variances Methodology and Assumption Changes COVID-19 Methodlogy and Assumption Changes Total before Economic Impact Experience Variances Methodology and Assumption Changes Components below the line Jun-20 Economic Non-economic 32.9bn 35.4bn 31.8bn COVID-19 Pre-COVID-19 and economic VNB (Rm) Life: Annualised VNB margin (%) Life: 59% 25% 16% Expenses Economic COVID-19 -- 56 of 84 -- 57 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 New business Rm Assets under administration Rbn Normalised operating profit Rm to R2 667m to R99bn to R830m 20 16 20 17 20 18 20 19 20 20 2016 2017 2018 2019 2020 -- 57 of 84 -- 58 Compelling offering has led to good business outcomes 100 112 117 104 105 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 DSY AuM Industry AuM Extending Shared-Value Model to offshore Assets under management growth Shared-Value metrics invested in preferred funds reduced withdrawals lower drawdowns more ad-hoc contributions Market rate: R 17.51 Currency enhancer rate: R 16.29 Currency Enhancer Buy in below the prevailing exchange rate on qualifying investment choices with the Global Endowment Global Portfolios Risk profiled investment Multi-fund active-passive BlackRock & 3rd party asset managers Offshore ZAR/USD New Foreign currency access at 7% below market rate Efficient and flexible international investment -- 58 of 84 -- 59 to 94%* to R246m (excl. Commercial) to R3 666m* 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 to R1 089m* 109 94 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 Gross written premium New business Combined ratio Normalised operating profit Market share in GWP 2016 2017 2018 2019 2020 *Personal Lines only. Assumes 6% in GWP market growth since 2018 *Personal Lines only -- 59 of 84 -- 60 Insure’s performance through COVID-19 was remarkable New business Discovery Insure’s internal credit rating system has produced a book with a remarkably credit-worthy profile Lapses Claims New business has recovered and is producing record sales levels Expected the claims outcome due to less exposure on the roads June and July numbers may be understated as lapse experience to complete run-off due to Gap in Cover offering 127% 137% 124% 32% 68% 111% 107% Jan Feb Mar Apr Mar Jun Jul 2019 level 100 111 106 64 62 66 77 Jan Feb Mar Apr May Jun Jul 100 103 87 59 66 39 86 Jan Feb Mar Apr May Jun Jul Jan20 level Jan20 level -- 60 of 84 -- 61 UK COMPOSITE MODEL PARTNER COMPOSITE MODEL SA COMPOSITE MODEL -- 61 of 84 -- 62 New business Earned premiums Normalised operating profit Lives covered to £126.3m GBP millions to 1.3m lives 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 GBP millions to £785.5m to £28.3m GBP millions 2016 2017 2018 2019 2020 Operating profit pre-COVID-19 +28% Net economic impact Normalised operating profit Operating profit before reserving for future COVID-19 impact 2016 2017 2018 2019 2020 -- 62 of 84 -- 63 UK businesses were resilient 500 000 home workouts 101% increase in benefit registrations 1.2m vouchers issued 295 000 vouchers issued The businesses came together under the ‘One Vitality’ banner Established group governance structures Consolidation of functions Composite member experience Group VH VL VI Operations Retentions VH Operations Retentions VL Operations Retentions Group + Rapidly responded to COVID-19 by adapting benefits and rewards with Vitality at Home -- 63 of 84 -- 64 to £62.7m GBP millions New business Lives covered Normalised operating profit to 682k lives to £42.0m after allowance for deferred claims GBP millions Earned premiums GBP millions to £496.7m 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 Allowance for deferred claims Operating profit Operating profit pre-COVID-19 +89% -- 64 of 84 -- 65 Vitality Health’s response to deliver value in a dynamic and evolving environment Maintained provision of critical care Increased utilisation of digital care Fast-tracked launch of Member Care Hub Launched COVID-19 Cash Benefit Pays £250 per night for the first 8 nights, plus £500 for each night in hospital thereafter, up to a maximum of £5 000 Vitality GP appointments GP Advice Line members accessing the hub since March Take-up of straight through care requests following launch 0 1,000 2,000 3,000 4,000 0% 10% 20% 30% 40% 23 March 30 March 6 April 13 April 20 April 27 April 4 May 11 May 18 May Users % users requesting care online Week beginning % requesting care online Care Hub Users 100% 99% May to July 2019 May to July 2020 Cancer and other urgent treatments continued throughout lockdown Mar-Jun20 vs Jul19-Feb20 Mar-Jun20 vs Jul19-Feb20 Adapted the Vitality programme Activity levels for members who bought a device during lockdown Up to 50% off selected devices 0 100 200 300 400 500 600 700 800 900 Base Early lockdown Current MET -minutes per week +18% -- 65 of 84 -- 66 Cash generated from inforce Write new business Invest in project initiatives Net cash generated COVID allowance Excellent retention and cash generation Lapse rates sustained at low levels despite COVID-19 Strong cash generation £58m £122m FY16 FY17 FY18 FY19 FY20 0% 20% 40% 60% 80% 100% 120% Jan Feb Mar Apr May Jun Jul Aug Lapse rate Lapse rate Actual vs Expected -- 66 of 84 -- 67 2016 2017 2018 2019 2020 to £63.6m GBP millions to 621k lives to -£13.8m GBP millions New business Lives covered Normalised operating profit Earned premiums to £288.8m GBP millions 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 Operating profit pre-COVID-19 -52% Net economic impact Normalised operating profit Operating profit before reserving for future COVID-19 impact -- 67 of 84 -- 68 Management actions to return VL to robust profitability are now in place Intervened against ‘high lapse’ brokers >100 firms’ 2 year agencies closed Restructured franchise channel From 24 to 13 franchises, £3.4m saving Consolidated ops and service at Group level Better consistent service and customer experience across Vitality, 12% reduction in expenses through synergies Enhanced retention capabilities Aims to eliminate experience variances Strengthened actuarial bases and set up COVID-19 provisions £29m impact Entered into interest rate hedge Protects against liquidity impact of further falls in interest rates, allows participation in upside > 140bps, and extends time to transition to longer term strategy Deferred Part VII transfer Defers need to inject significant capital into VL for 3 years Changed Group legal entity structure Capital benefit of >£125m Adapted elements of actuarial methodology £23.5m reduction in SCR for 30 June 2020 Sourced liquidity funding in the UK £100m facility at 2% plus Libor Area Impact Management actions OPERATIONS CAPITAL LIQUIDITY Progress 1 2 3 4 5 8 9 10 7 6 Implemented Nov ’19 and May’20 Completed Apr ‘20 Completes Aug ‘20 Ongoing process, good traction Effective from Jul ‘20 Implemented Feb ‘20 Implemented Sep ‘19, Jul ‘20 Confirmed Mar ‘20 Agreed Feb ‘20 Extended Jun ‘20 -- 68 of 84 -- 69 -20 -10 - 10 20 30 40 FY17 FY18 FY19 FY20 FY21 Millions COVID-19 and interest rates impacted the period; expect profits to revert -80 -60 -40 -20 0 20 40 Plan Operating profit pre COVID-19 provision COVID-19 provision Normalised operating profit Interest rate impact Operating profit £24m -£61m -£74m -£29m £15m -£13m Earnings impact Expect operating profits to revert in FY21 Indicative only, assumes no change in hedging costs, no assumption changes and a range to reflect potential experience variances Uncertainty inherent in experience Range Substantial value if interest rates rise - 200 400 600 800 1,000 1,200 1,400 1,600 1,800 Will increase discretionary margins Hedge gives away upside for the first +/- 100bps after which there is upside in the form of higher discretionary margins/P&L Operating profit £945k per 1bps sensitivity for IFRS reserve* *Decreasing the higher interest rates go Value impact (Rm) Expected Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors -- 69 of 84 -- 70 PARTNER COMPOSITE MODEL -- 70 of 84 -- 71 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 Integrated API by insurance partners Revenue2 Operating result Insurance and franchise partners membership All numbers exclude new VG initiatives, i.e. AIA Health and Vitality1 1 From insurance partners 2016 2017 2018 2019 2020 Vitality USA Insurance Partners 2016 2017 2018 2019 2020 R15.8bn USD1.0bn R1.1bn USD72.3m R308m USD19.6m 117% CAGR 1.8m 2 Excludes services related to system implementation and other cost recoveries and rewards -- 71 of 84 -- 72 Execution of business strategy with partners has taken place rapidly Exploit latent potential and scale Rapid market expansion and penetration Pursue Shared-Value adjacencies and partnerships New business unit to expand global health insurance initiatives 1 National Champions Powered By Vitality Franchise Markets Vitality Health International USA PROGRAMS PARTNERS FITNESS GROCERS TRAVEL ACTIVE REWARDS OTHER PLATFORM SUPPORT ACTIVE REWARDS VITALITY DRIVE VITALITY FOR SENIORS CONDITION MANAGEMENT VITALITY DISTRIBUTION PRODUCTS VITALITY FUNDS UPFRONT DISCOUNT COVER BOOST PREMIUM FLEX DATA* CASHBACK >20M VITALITY LIVES >4M ACTIVE DEVICES >40M LIFE YEARS 24M WORKOUTS PER WEEK *Data metrics across Discovery Group -- 72 of 84 -- 73 The case for Shared-Value Insurance is getting stronger Risk is behavioural and traditional models are exposed Traditional insurance pricing models PREMIUM TIME Flat market premium Underwritten at inception Traditional models pool controllable risk, which is inefficient, creates adverse selection and selective lapsation Shared-Value Insurance Model has no trade-offs Vitality has codified behaviour and risk Dynamic pricing model Sales & Selection effect Behavioural effect Lapse effect 65 73 81 89 97 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 Age 0-0.1 0.1-0.2 0.2-0.3 0.3-0.4 0.4-0.5 0.5-0.6 0.6-0.7 0.7-0.8 0.8-0.9 0.9-1 Over 25 years in behavioural insurance, and in collaboration with leading academic institutions mortality has been codified in over 1m curves for each age based on different wellness and health engagement behaviours Lower cost of insurance 7% -15% Lower lapse rates by health engagement 30% -70% Increase in VNB margin 10% -50% Pricing of behaviour over the currency of the insurance contract Aligned to recognition of cohorts IFRS 17 Improvement in health outcomes Up to 40% -- 73 of 84 -- 74 The Shared-Value Model creates true profitability Market A Base EV from new business Increased sales Increased repurchases Improved assumptions Vitality premium Insurance rewards Vitality rewards Other Vitality costs c40% incremental EV from new business through Vitality Vitality EV from new business • Internal value impact analysis performed by market • Significant sales impact of Vitality through both incremental new business and cross-purchases • Costs include all incremental costs associated with programme EV = Enterprise Value -- 74 of 84 -- 75 National Champions exhibit continued strong performance IP VoNB = Integrated Premium Value of New Business 1. AIA Group 2020 Interim Results 2. % members that earned a point for physical activity in last 3 months (Q2 2020) 3. FY2019 customer survey 2015 2017 2019 Vitality IP VoNB Since launch, Vitality IP VoNB has nearly doubled every year Rapid membership growth Engaging in some form of exercise because of Vitality3 84%More aware of their health3 90% +450K members in <2 years %2 members active well above average amidst COVID-19 Market average 55% 28% Higher repurchase rates for highly engaged members1 +80% Larger case sizes for Vitality members1 2X Up to Up to AIA embedded Vitality in its global strategy, executing the Shared-Value insurance model across Asia Pacific ‘All-in’ +91% CAGR Launch +79% Sept'18 Dec'18 Jun'19 Dec'19 Jun'20 Total Vitality linked sales (Germany) 2019 2020 very well received Re-launched Vitality in existing markets in quick succession, following a seamless migration onto the V1 platform Plans to roll-out Vitality across Europe in 2021/2022 +43% -- 75 of 84 -- 76 World-class technology solution V 1 P L A T F O R M to operate to implement to configure V1 availability For 80% of points to calculate VDP availability Readings per day Health assessments Goals achieved Plethora of integrated reward partners Live markets Internationally recognised information security management system Strong, central product development roadmap -- 76 of 84 -- 77 2016 2017 2018 2019 2020 New business1 Written premium1 PAH’s operating result pre-tax DSY’s operating result after tax and management expenses to R14.3bn to R29.8bn to R1.9bn (DSY’s share is R464m) to R182m 1 100% of PAH 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 2016 2017 2018 2019 2020 -- 77 of 84 -- 78 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Continued focus on quality business and investment in future capabilities Headcount growth in technology skills Quality business and operational excellence Tech headcount split at head office 0% 20% 40% 60% 80% 100% Jun-18 Dec-18 Jun-19 Dec-19 Jun-20 Tech Non-tech Customer reapplication rate individual business Combined operating ratio % claims settled within 1 day Persistency Service levels Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Target Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Target -- 78 of 84 -- 79 Large market opportunity but a changing competitive landscape High growth expected from Chinese healthcare market Internet giants gaining traction within PHI Medical expenditure Source: World Health Organisation and Ernst and Young Growth rate of world’s top 5 healthcare markets Source: Data from the World Health Organisation as of end 2017 -5% 0% 5% 10% 15% 20% China USA Japan Germany France 10Y 5Y 2020 Jun 2019 Jun Source: Ping An Health. PICC Health total reported revenue is 22.775bn, however 6.75 bn is considered business that is comparable with PAH. The remainder is mostly government related administrative business 55% 74% 590% 222% 0% 20% 40% 60% 80% 100% 120% China US Germany UK Individual Expenditure Commercial Insurance Social Medical Insurance -- 79 of 84 -- 80 Maintaining growth through distribution, the app and diversifying the product offering Distribution Expanding distribution footprint* Tier-2 branches (provincial level) of revenue online (YTD) Developing in full swing in greater Guangdong area Expanding East China market steadily Strong presence in North China Building presence in Southwest *Only Mainland China depicted Tier-3 branches (city level) NEW 20YR MEDICAL REIMBURSEMENT PRODUCT WITH DYNAMIC PRICING Complete annual health declaration Submit verified health data Ongoing physical activity Score gives health status Premium discount based on status 1 2 3 5 4 Online sales capability Number of app users (m) 0 5 10 15 20 25 30 35 Millions -- 80 of 84 -- 81 Excellent results from Ping An Run Vitality Improved up-selling Lower surrender rates Lower medical costs Largest Vitality programme Additional policies Lower surrenders Lower cost per event 2018 2019 2020 Members, 4 years since inception 6m 5m 3m RUN not activated RUN activated RUN not activated RUN activated Inactive Highly active RUN not activated RUN activated Inactive Highly active -59% -10% +26% -23% -6% Ping An Run Vitality is offered to all Ping An Fu policyholders purchasing after September 2016. Ping An Fu is Ping An Life’s flagship critical illness product Based on Ping An Life’s JianXiang and Zhuyuan rider products, which cover hospital-related expenses -- 81 of 84 -- 82 Synergistic opportunities from the Ping An Health Ecosystem Ping An Group is building a comprehensive ecosystem - 200 400 600 800 1,000 1,200 Public Private Revenue for healthcare services in China (US$bn) Source: NHFPC company analysis Ping An Group seeks to capture the rapid growth expected from the Chinese private healthcare market Private market worth cUSD200bn Patient Provider Payer Ping An Technology Ping An Health Konnect Ping An Smart City Ping An Good Doctor Ping An Shionogi Co Largest online healthcare services platform Administers managed healthcare platforms for government-funded Social Health Insurance funds B2B digital services (AI, cloud computing, blockchain, big data) Joint venture building a data-driven drug development platform, using AI technology 346m Registered users 1st Global leader in fintech patent applications Cities in China >800m 200 People Uses of AskBob bot 17k+ 22m Medical institutions 825m Online consultations Smart integrated platform for medical regulators and medical service providers Source: Ping An Group 2020 Interim Results report Specialist health insurer -- 82 of 84 -- 83 Perfect composite model, #1 in every industry, and laboratory for shared value in financial services. A successful entry into banking The best insurer in the UK, making use of a composite Shared-Value Model Vitality is the world’s largest and most sophisticated behavioural platform linked to financial services, with disciplined execution Ping An Health delivers on its plan to become the leading health insurer in China with over 50m clients Focused on capital strength and liquidity Operating performance was resilient Interest rate movements impacted headline earnings COVID-19 reserve to cater for all future COVID-19 impacts Growth engine remains robust -- 83 of 84 -- 84 84 for the year ended 30 June 2020 -- 84 of 84 --